New developments in the management of hepatitis C virus infection: focus on boceprevir
Marina Berenguer,1–3 F Xavier López-Labrador4–61Hepatology-Liver Transplantation Unit, Digestive Medicine Service, Hospital Universitari La Fe, Valencia, Spain; 2Department of Medicine, University of Valencia, Valencia, Spain; 3CIBERehd, Instituto de Salud...
Guardado en:
Autores principales: | Berenguer M, López-Labrador FX |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76dc9770a0764ccb96417a8c9b27b59f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
por: D'Ambrosio R, et al.
Publicado: (2012) -
New treatment options in the management of IBD – focus on colony stimulating factors
por: Josué Barahona-Garrido, et al.
Publicado: (2008) -
Impact of Hepatitis C Virus Co-Infection on Tuberculous Patients
por: Eman Nageeb, et al.
Publicado: (2021) -
A new evolutionary model for hepatitis C virus chronic infection.
por: Rebecca R Gray, et al.
Publicado: (2012) -
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa
por: Liu CH, et al.
Publicado: (2014)